58
Views
13
CrossRef citations to date
0
Altmetric
Case Report

Paroxetine Use Throughout Pregnancy: Does It Pose Any Risk to the Neonate?

, M.D., , M.D., , M.D., , M.D. & , M.D.
Pages 97-100 | Received 28 May 2003, Accepted 24 Oct 2003, Published online: 15 Mar 2004
 

Abstract

A newborn of a SSRI‐treated mother presented with lethargy, no crying, and no response to tactile stimulation. EEG findings were abnormal. Laboratory and clinical evaluations were normal. He recovered at the age of two weeks. Serotonin is a neurotransmitter that has an important roll in pain modulation during fetal neurodevelopment. We suspect these symptoms are attributed to the intrauterine exposure to paroxetine, through modulation of pain signals.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.